PTCy: The “new” standard for GVHD prophylaxis

IF 6.9 2区医学 Q1 HEMATOLOGY

Blood Reviews Pub Date : 2023-11-01 DOI:10.1016/j.blre.2023.101096

Andrea Bacigalupo , Richard Jones

引用次数: 0

Abstract

High dose Post transplant cyclophosphamide (PTCy) is now regarded as a very effective way of preventing acute and chronic GvHD, and it's use has rapidly expanded world-wide.

查看原文本刊更多论文

PTCy: GVHD预防的“新”标准

移植后大剂量环磷酰胺(PTCy)被认为是预防急性和慢性GvHD的一种非常有效的方法，其应用已在世界范围内迅速扩大。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Blood Reviews 医学-血液学

CiteScore

13.80

自引率

1.40%

发文量

期刊介绍： Blood Reviews, a highly regarded international journal, serves as a vital information hub, offering comprehensive evaluations of clinical practices and research insights from esteemed experts. Specially commissioned, peer-reviewed articles authored by leading researchers and practitioners ensure extensive global coverage across all sub-specialties of hematology.